Stay updated on Atezolizumab Combos in Untreated Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab Combos in Untreated Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Atezolizumab Combos in Untreated Hepatocellular Carcinoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe study has reduced its number of locations from 232 to 174, indicating a significant decrease in available sites for participation. Additionally, several specific locations across various states and countries have been withdrawn from the study.SummaryDifference21%
- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedThe page has updated its content to reflect new dates and locations, including the addition of specific cities and the removal of outdated entries. Notably, the status of certain entries has changed from 'Recruiting' to 'Withdrawn'.SummaryDifference2%
- Check44 days agoChange DetectedThe website has updated to revision v2.14.2, noting that some NLM-NCBI services are experiencing heavy traffic, which may impact performance and availability.SummaryDifference0.7%
- Check65 days agoChange DetectedThe study has expanded to include 232 locations, adding numerous hospitals and medical centers across the United States, Brazil, China, and several other countries, while removing 237 locations from the previous version.SummaryDifference24%
- Check73 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
- Check94 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.0%
Stay in the know with updates to Atezolizumab Combos in Untreated Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab Combos in Untreated Hepatocellular Carcinoma Clinical Trial page.